Sigma Healthcare Limited
SIG
Rang in aandelen
#1057
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Aandeelprijs
$1.94
Marktkapitalisatie
$22.27B
Verandering (1 dag)
-0.72%
Verandering (1 jaar)
-1.89%
Land
AU
Handel Sigma Healthcare Limited (SIG)
Categorie
Healthcare
Aantal uitstaande aandelen voor Sigma Healthcare Limited (SIG)
Aantal uitstaande aandelen per June 2026: 11.50B
Volgens de laatste financiële rapporten en de aandelenkoers van Sigma Healthcare Limited bedraagt het huidige aantal uitstaande aandelen 11.50B. Aan het einde van January 2024 had het bedrijf 1.02B uitstaande aandelen. Het aantal uitstaande aandelen wordt meestal beïnvloed door aandelensplitsingen en terugkoop van aandelen.
Geschiedenis van uitstaande aandelen van Sigma Healthcare Limited (SIG) van 2001 tot 2026
Uitstaande aandelen aan het einde van elk jaar
| Jaar | Uitstaande aandelen | Wijzigen |
|---|---|---|
| 2026 (TTM) | 11.50B | 631.89% |
| 2025 | 1.57B | 53.41% |
| 2024 | 1.02B | 0.23% |
| 2023 | 1.02B | 0.19% |
| 2022 | 1.02B | 0.28% |
| 2021 | 1.02B | 0.65% |
| 2020 | 1.01B | -0.29% |
| 2019 | 1.01B | -2.47% |
| 2018 | 1.04B | -2.36% |
| 2017 | 1.06B | 0.68% |
| 2016 | 1.06B | -3.75% |
| 2015 | 1.10B | 2.07% |
| 2014 | 1.08B | -31.47% |
| 2013 | 1.57B | 31.42% |
| 2012 | 1.20B | -0.31% |
| 2011 | 1.20B | 21.66% |
| 2010 | 985.46M | -37.25% |
| 2009 | 1.57B | 0.00% |
| 2008 | 1.57B | 0.00% |
| 2007 | 1.57B | 0.00% |
| 2006 | 1.57B | 0.00% |
| 2004 | 1.57B | 0.00% |
| 2003 | 1.57B | 0.00% |
| 2002 | 1.57B | 0.00% |
| 2001 | 1.57B | 0.00% |
Uitstaande aandelen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Uitstaande aandelen | Verschil | Land |
|---|---|---|---|
| 118.70M | -98.97% |
US
|
|
| - | - |
US
|
|
| 236.00M | -97.95% |
US
|
|
| - | - |
US
|
|
| 113.45M | -99.01% |
US
|
